Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantatio
Recruiting
- Conditions
- Aortic Valve Stenosis
- Registration Number
- NL-OMON26988
- Lead Sponsor
- St Antonius Hospital, Nieuwegein, the Netherlands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 858
Inclusion Criteria
Planned transfemoral transcatheter aortic valve implantation procedure
- Established indication for oral anticoagulation
- Written informed consent
Exclusion Criteria
Patients at high risk for thromboembolism for who interruption of oral anticoagulants is no option:
- Mechanical heart valve prosthesis
- Intracardiac thrombus
< 3 months after venous thromboembolism
< 6 months after transient ischemic attack or stroke in patients with atrial fibrillation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method